Advertisement

Journal of Pharmaceutical Innovation

, Volume 12, Issue 1, pp 62–75 | Cite as

Influence of HPMC K100LV and Compritol® HD5 ATO on Drug Release and Rheological Behavior of HPMC K4M Matrix Tablets

  • Rania HamedEmail author
  • Ali Al-Samydai
  • Tamadur Al Baraghthi
  • Ola Tarawneh
  • Suhair Sunoqrot
Original Article

Abstract

Purpose

The objectives of this study were to develop once-a-day oral controlled-release tablets of quetiapine fumarate (QF) and to determine the effect of polymer type, viscosity grade, polymer ratio, and polymer rheological properties on the rate of QF release from hydroxypropyl methylcellulose (HPMC) matrix tablets.

Methods

Tablets were prepared from low-viscosity-grade HPMC K100LV (K100LV), high-viscosity-grade HPMC K4M (K4M), Compritol® HD5 ATO (PEGylated glyceryl behenate (PGB)), and binary combinations of these polymers. In vitro drug release from all tablets was evaluated over 24 h.

Results

In vitro drug release studies revealed that formulations containing K100LV/K4M and PGB/K4M at a ratio of 170:70 resulted in similar release profiles which extended for 24 h (f2 > 50). QF release kinetics followed either diffusion, anomalous transport, case II transport, or super case II transport, as fitted by the Korsmeyer-Peppas model. Tablet swelling and erosion studies were consistent with dissolution profiles. A linear relationship between % swelling and % QF released was observed in tablets containing K4M alone or in combination with K100LV or PGB, indicating the direct role of polymer swelling in controlling the mechanism of drug release. The viscoelastic properties of single and binary polymeric gels made with the three polymers (K100LV, K4M, and PGB) corroborated the in vitro release studies of QF tablets.

Conclusions

Our results provide evidence that blending polymers with different viscosities and hydrophilicities can result in unique matrices with tunable release profiles.

Keywords

Controlled-release tablets Hydroxypropyl methylcellulose PEGylated glyceryl behenate (Compritol® HD5 ATO) Release kinetics Swelling Erosion Viscoelastic properties 

Notes

Acknowledgements

This project was financially supported by the Deanship of Academic Research and Graduate Studies at Al-Zaytoonah University of Jordan. The authors would like to thank Hikma Pharmaceuticals for providing tableting facilities.

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Asare-Addo K, Supuk E, Mahdi MH, Adebisi AO, Nep E, Conway BR, Kaialy W, Al-Hamidi H, Nokhodchi A. Drug release from E chemistry hypromellose tablets using the Bio-Dis USP type III apparatus: an evaluation of the effect of systematic agitation and ionic strength. Colloids Surf B: Biointerfaces. 2016;143:481–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Mujtaba A, Kohli K. In vitro/in vivo evaluation of HPMC/alginate based extended-release matrix tablets of cefpodoxime proxetil. Int J Biol Macromol. 2016;89:434–41.CrossRefPubMedGoogle Scholar
  3. 3.
    Jain AK, Söderlind E, Viridén A, Schug B, Abrahamsson B, Knopke C, Tajarobi F, Blume H, Anschütz M, Welinder A. The influence of hydroxypropyl methylcellulose (HPMC) molecular weight, concentration and effect of food on in vivo erosion behavior of HPMC matrix tablets. J Control Release. 2014;187:50–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Sankalia JM, Sankalia MG, Mashru RC. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC. J Control Release. 2008;129(1):49–58.CrossRefPubMedGoogle Scholar
  5. 5.
    Aguilar-de-Leyva Á, Cifuentes C, Rajabi-Siahboomi AR, Caraballo I. Study of the critical points and the role of the pores and viscosity in carbamazepine hydrophilic matrix tablets. Eur J Pharm Biopharm. 2012;80(1):136–42.CrossRefPubMedGoogle Scholar
  6. 6.
    Gil EC, Colarte AI, Bataille B, Pedraz JL, Rodriguez F, Heinamaki J. Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride. Int J Pharm. 2006;317(1):32–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliver Rev. 2012;64(Supplement (0)):163–74.CrossRefGoogle Scholar
  8. 8.
    Cao QR, Choi YW, Cui JH, Lee BJ. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen. J Control Release. 2005;108(2–3):351–61.CrossRefPubMedGoogle Scholar
  9. 9.
    Joshi SC. Sol-gel behavior of hydroxypropyl methylcellulose (HPMC) in ionic media including drug release. Materials. 2011;4(10):1861–905.CrossRefGoogle Scholar
  10. 10.
    Samani SM, Montaseri H, Kazemi A. The effect of polymer blends on release profiles of diclofenac sodium from matrices. Eur J Pharm Biopharm. 2003;55(3):351–5.CrossRefPubMedGoogle Scholar
  11. 11.
    Velasco MV, Ford JL, Rowe P, Rajabi-Siahboomi AR. Influence of drug:hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablets. J Control Release. 1999;57(1):75–85.CrossRefPubMedGoogle Scholar
  12. 12.
    De Brabander C, Vervaet C, Remon JP. Development and evaluation of sustained release mini-matrices prepared via hot melt extrusion. J Control Release. 2003;89(2):235–47.CrossRefPubMedGoogle Scholar
  13. 13.
    Koffi AA, Agnely F, Ponchel G, Grossiord JL. Modulation of the rheological and mucoadhesive properties of thermosensitive poloxamer-based hydrogels intended for the rectal administration of quinine. Eur J Pharm Sci. 2006;27(4):328–35.CrossRefPubMedGoogle Scholar
  14. 14.
    Gonçalves-Araújo T, Rajabi-Siahboomi AR, Caraballo I. Application of percolation theory in the study of an extended release verapamil hydrochloride formulation. Int J Pharm. 2008;361(1):112–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Missaghi S, Fegely KA, Rajabi-Siahboomi AR. Investigation of the effects of hydroalcoholic solutions on textural and rheological properties of various controlled release grades of hypromellose. AAPS PharmSciTech. 2009;10(1):77–80.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Hiremath PS, Saha RN. Oral matrix tablet formulations for concomitant controlled release of anti-tubercular drugs: design and in vitro evaluations. Int J Pharm. 2008;362(1–2):118–25.CrossRefPubMedGoogle Scholar
  17. 17.
    Hewlett KO, L’Hote-Gaston J, Radler M, Shull KR. Direct measurement of the time-dependent mechanical response of HPMC and PEO compacts during swelling. Int J Pharm. 2012;434(1–2):494–501.CrossRefPubMedGoogle Scholar
  18. 18.
    Dvořáčková K, Doležel P, Mašková E, Muselík J, Kejdušová M, Vetchý D. The effect of acid pH modifiers on the release characteristics of weakly basic drug from hydrophlilic–lipophilic matrices. AAPS PharmSciTech. 2013;14(4):1341–8.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Defang O, Shufang N, Wei L, Hong G, Hui L, Weisan P. In vitro and in vivo evaluation of two extended release preparations of combination metformin and glipizide. Drug Dev Ind Pharm. 2005;31(7):677–85.CrossRefPubMedGoogle Scholar
  20. 20.
    Yang L, Fassihi R. Modulation of diclofenac release from a totally soluble controlled release drug delivery system. J Control Release. 1997;44(2):135–40.CrossRefGoogle Scholar
  21. 21.
    Mehta RY, Missaghi S, Tiwari SB, Rajabi-Siahboomi AR. Application of ethylcellulose coating to hydrophilic matrices: a strategy to modulate drug release profile and reduce drug release variability. AAPS PharmSciTech. 2014;15(5):1049–59.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Aburahma MH, Badr-Eldin SM. Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals. Expert Opin Drug Deliv. 2014;11(12):1865–83.CrossRefPubMedGoogle Scholar
  23. 23.
    Jannin V, Berard V, N’Diaye A, Andres C, Pourcelot Y. Comparative study of the lubricant performance of Compritol (R) 888 ATO either used by blending or by hot melt coating. Int J Pharm. 2003;262(1–2):39–45.CrossRefPubMedGoogle Scholar
  24. 24.
    N’Diaye A, Jannin V, Berard V, Andres C, Pourcelot Y. Comparative study of the lubricant performance of Compritol (R) HD5 ATO and Compritol (R) 888 ATO: effect of polyethylene glycol behenate on lubricant capacity. Int J Pharm. 2003;254(2):263–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Barakat NS, Elbagory IM, Almurshedi AS. Controlled-release carbamazepine granules and tablets comprising lipophilic and hydrophilic matrix components. AAPS PharmSciTech. 2008;9(4):1054–62.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Ibrahim MA, Fouad EA, El-Badry M. Employing Compritol in a mixed matrix for sustaining chlorpheniramine maleate release: kinetic study. Dig J Nanomater Bios. 2013;8(2):737–46.Google Scholar
  27. 27.
    Li FQ, JH H, Deng JX, Su H, Xu S, Liu JY. In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets. Int J Pharm. 2006;324(2):152–7.CrossRefPubMedGoogle Scholar
  28. 28.
    Goldstein JM. Quetiapine fumarate (Seroquel (R)): a new atypical antipsychotic. Drugs Today. 1999;35(3):193–210.CrossRefPubMedGoogle Scholar
  29. 29.
    Gil EC, Colarte AI, Bataille B, Pedraz JL, Rodríguez F, Heinämäki J. Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride. Int J Pharm. 2006;317(1):32–9.CrossRefPubMedGoogle Scholar
  30. 30.
    US FDA dissolution methods for quetiapine fumarate extended release and conventional tablets. http://www.accessdata.fda.gov/scripts/cder/dissolution/dsp_SearchResults_Dissolutions.cfm. Accessed 12 November 2015
  31. 31.
    Costa P, Manuel J, Lobo S. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123–33.CrossRefPubMedGoogle Scholar
  32. 32.
    Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15(1):25–35.CrossRefGoogle Scholar
  33. 33.
    Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985;60(4):110–1.PubMedGoogle Scholar
  34. 34.
    Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release. 1987;5(1):37–42.CrossRefGoogle Scholar
  35. 35.
    Ferrero C, Massuelle D, Doelker E. Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. II. Evaluation of a possible swelling-controlled drug release mechanism using dimensionless analysis. J Control Release. 2010;141(2):223–33.CrossRefPubMedGoogle Scholar
  36. 36.
    Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res. 2006;23(12):2709–28.CrossRefPubMedGoogle Scholar
  37. 37.
    Wang M, Winter HH, Auernhammer GK. Time and frequency dependent rheology of reactive silica gels. J Colloid Interface Sci. 2014;413:159–66.CrossRefPubMedGoogle Scholar
  38. 38.
    Rudraraju VS, Wyandt CM. Rheology of microcrystalline cellulose and sodiumcarboxymethyl cellulose hydrogels using a controlled stress rheometer: part II. Int J Pharm. 2005;292(1–2):63–73.CrossRefPubMedGoogle Scholar
  39. 39.
    Rajabi-Siahboomi AR, Bowtell RW, Mansfield P, Davies MC, Melia CD. Structure and behavior in hydrophilic matrix sustained release dosage forms: 4. Studies of water mobility and diffusion coefficients in the gel layer of HPMC tablets using NMR imaging. Pharm Res. 1996;13(3):376–80.CrossRefPubMedGoogle Scholar
  40. 40.
    Jones DS, Muldoon BCO, David Woolfson A, Dominic Sanderson F. Rheological destructuring of aqueous gels composed of cellulose ethers following storage in the presence of redox agents. J Appl Polym Sci. 2005;98(2):852–9.CrossRefGoogle Scholar
  41. 41.
    Mourao SC, da Silva C, Bresolin TMB, Serra CHR, Porta V. Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet. Int J Pharm. 2010;386(1–2):201–7.CrossRefPubMedGoogle Scholar
  42. 42.
    Huanbutta K, Sriamornsak P, Limmatvapirat S, Luangtana-anan M, Yoshihashi Y, Yonemochi E, Terada K, Nunthanid J. Swelling kinetics of spray-dried chitosan acetate assessed by magnetic resonance imaging and their relation to drug release kinetics of chitosan matrix tablets. Eur J Pharm Biopharm. 2011;77(2):320–6.CrossRefPubMedGoogle Scholar
  43. 43.
    Efentakis M, Pagoni I, Vlachou M, Avgoustakis K. Dimensional changes, gel layer evolution and drug release studies in hydrophilic matrices loaded with drugs of different solubility. Int J Pharm. 2007;339(1):66–75.CrossRefPubMedGoogle Scholar
  44. 44.
    Tiwari SB, Rajabi-Siahboomi AR (2008) Modulation of drug release from hydrophilic matrices. Pharm Tech Eur 1.Google Scholar
  45. 45.
    Akinosho H, Hawkins S, Wicker L. Hydroxypropyl methylcellulose substituent analysis and rheological properties. Carbohydr Polym. 2013;98(1):276–81.CrossRefPubMedGoogle Scholar
  46. 46.
    Viridén A, Wittgren B, Larsson A. Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets. Eur J Pharm Sci. 2009;36(2):297–309.CrossRefPubMedGoogle Scholar
  47. 47.
    Baumgartner S, Kristl J, Peppas NA. Network structure of cellulose ethers used in pharmaceutical applications during swelling and at equilibrium. Pharm Res. 2002;19(8):1084–90.Google Scholar
  48. 48.
    Mahdi MH, Diryak R, Kontogiorgos V, Morris GA, Smith AM. In situ rheological measurements of the external gelation of alginate. Food Hydrocoll. 2016;55:77–80.Google Scholar
  49. 49.
    Sekiguchi Y, Sawatari C, Kondo T. A gelation mechanism depending on hydrogen bond formation in regioselectively substituted O-methylcelluloses. Carbohydr Polym. 2003;53(2):145–53.Google Scholar
  50. 50.
    Shandryuk GA, Kuptsov SA, Shatalova AM, Plate NA, Talroze RV. Liquid crystal H-bonded polymer networks under mechanical stress. Macromolecules. 2003;36(9):3417–23.Google Scholar
  51. 51.
    Silva SMC, Pinto FV, Antunes FE, Miguel MG, Sousa JJS, Pais AACC. Aggregation and gelation in hydroxypropylmethyl cellulose aqueous solutions. J Colloid Interface Sci. 2008;327(2):333–40.Google Scholar
  52. 52.
    Hiremath PS, Saha RN. Controlled release hydrophilic matrix tablet formulations of isoniazid: design and in vitro studies. AAPS PharmSciTech. 2008;9(4):1171–8.Google Scholar
  53. 53.
    Moreira HR, Munarin F, Gentilini R, Visai L, Granja PL, Tanzi MC, Petrini P. Injectable pectin hydrogels produced by internal gelation: pH dependence of gelling and rheological properties. Carbohydr Polym. 2014;103:339–47.Google Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • Rania Hamed
    • 1
    Email author
  • Ali Al-Samydai
    • 1
  • Tamadur Al Baraghthi
    • 1
  • Ola Tarawneh
    • 1
  • Suhair Sunoqrot
    • 1
  1. 1.Department of Pharmacy, Faculty of PharmacyAl-Zaytoonah University of JordanAmmanJordan

Personalised recommendations